Hepatic Hippo signaling inhibits development of HCC (32), and the MYC-mediated axis has been confirmed as a dominant part of HCC in terms of proliferation, migration, invasion, and drug resistance (33). The gene discussed is MYC; the disease is hepatocellular carcinoma.